Literature DB >> 9121775

Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding.

W D Chen1, G A Otterson, S Lipkowitz, S N Khleif, A B Coxon, F J Kaye.   

Abstract

Dephosphorylation of the RB protein has been reported to be associated with apoptosis. In contrast, we show that treatment of HL60 cells with etoposide or cytosine arabinoside or treatment of breast epithelial cells with alpha-FAS is associated with the cleavage of a 5 kDa fragment from the C-terminus of RB, resulting in a truncated product that we have designated as p100cl. This cleavage event coincides with the activation of cysteine proteases at the onset of apoptosis, is blocked by the addition of iodoacetamide to cells prior to the onset of apoptosis, and results in the expression of faster migrating protein species which can mimic dephosphorylated RB. The free 5 kDa fragment is detected only during apoptosis, predicts a cleavage site that we have mapped to a unique CPP32-like recognition sequence which is present at the C-terminus of all reported RB homologues, and results in a truncated RB protein with enhanced E2F binding affinity. While the causality for this cleavage event in the apoptotic process is still under investigation, our findings suggest distinct post-translational pathways for the RB product between cells examined during growth arrest (p105 hypophosphorylated RB) or apoptosis (p100cl).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121775     DOI: 10.1038/sj.onc.1201096

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis.

Authors:  J Padmanabhan; D S Park; L A Greene; M L Shelanski
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

Review 2.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

3.  Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.

Authors:  S Wang; N Nath; A Minden; S Chellappan
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

4.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system.

Authors:  D MacPherson; J Sage; D Crowley; A Trumpp; R T Bronson; T Jacks
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

7.  Actin cleavage in various tumor cells is not a critical requirement for executing apoptosis.

Authors:  R L Rice; D G Tang; J D Taylor
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

8.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

9.  p53 facilitates pRb cleavage in IL-3-deprived cells: novel pro-apoptotic activity of p53.

Authors:  E Gottlieb; M Oren
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

10.  Evidence for a mitochondrial localization of the retinoblastoma protein.

Authors:  Ioana Ferecatu; Nathalie Le Floch; Marie Bergeaud; Aida Rodríguez-Enfedaque; Vincent Rincheval; Lisa Oliver; François M Vallette; Bernard Mignotte; Jean-Luc Vayssière
Journal:  BMC Cell Biol       Date:  2009-06-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.